Alert Your Pharmacist to Rxs for Unapproved Ear Drops

September 2015

You'll see fewer Rx ear drops (antipyrine/benzocaine, A/B Otic, etc) for pain and inflammation on your shelves.

None of these ear drops with antipyrine and benzocaine were ever actually FDA-approved...INCLUDING the "newer" Auralgan reformulation.

Now FDA is cracking down on manufacturers of these and other unapproved otics that have been prescribed for decades.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Medication Errors Look Within Brand Names for Clues to a Med's Use
Cardiology Store Entresto in its Original Container
Influenza Offer Flu Vaccines as Soon as You Have Them Available
Look-Alike/Sound-Alike Watch for Patients on "High-Alert" Meds Picking up Supplements
Antipsychotics Clarify Rxs Written for Just "Invega"
Practice Alert Your Pharmacist to Rxs for Unapproved Ear Drops
Lice Point to "Directions for Use" on Lice Product Labeling
Cholesterol Include All Instructions on Praluent Rx Labels
Antibiotics Consider Including Length of Therapy on Antibiotic Rx Labels
NSAIDs Stay Alert for Patients Taking Multiple Sources of NSAIDs
Practice Double-Check if Your Pharmacy Needs REMS Certification
Practice Be ready when DEA brings back National Rx Drug Take-Back Day